| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Asthma | |||||
| Lung Diseases | |||||
| 2 | More general conditions related to this trial | ||||
| Bronchial Diseases | |||||
| Hypersensitivity | |||||
| Hypersensitivity, Immediate | |||||
| Immune System Diseases | |||||
| Lung Diseases, Obstructive | |||||
| Respiratory Hypersensitivity | |||||
| Respiratory Tract Diseases | |||||
| 3 | Interventions listed in this trial | ||||
| Albuterol | |||||
| Colchicine | |||||
| Adrenal Cortex Hormones | |||||
| Adrenergic-Beta Agonists | |||||
| 4 | More general drug interventions related to this trial | ||||
| Antimitotic Agents | |||||
| Antineoplastic Agents | |||||
| Antirheumatic Agents | |||||
| Gout Suppressants | |||||
| Mitosis Modulators | |||||
| Molecular Mechanisms of Pharmacological Action | |||||
| Pharmacologic Actions | |||||
| Therapeutic Uses | |||||
| Tubulin Modulators | |||||
| 5 | Sponsors listed in this trial | ||||
| National Heart, Lung, and Blood Institute (NHLBI) | |||||
|
